MEDICINOVA, INC. Pay versus Performance
The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.
- 2025-12-31: PEO Dr. Yuichi Iwaki; PEO total compensation $1.76M; PEO compensation actually paid $1.34M; Other NEO average total compensation $735.62K.
- 2024-12-31: PEO Dr. Yuichi Iwaki; PEO total compensation $1.41M; PEO compensation actually paid $1.61M; Other NEO average total compensation $424.60K.
- 2023-12-31: PEO Dr. Yuichi Iwaki; PEO total compensation $1.39M; PEO compensation actually paid $1.15M; Other NEO average total compensation $846.68K.
| Fiscal year end | PEO | PEO total compensation | PEO compensation actually paid | Other NEO average total compensation | Other NEO average compensation actually paid | Total shareholder return | Peer group total shareholder return | Net income | Company-selected measure | Proxy filed |
|---|
| 2025-12-31 | Dr. Yuichi Iwaki | $1.76M | $1.34M | $735.62K | $567.23K | $63.90 | | $12.00M | | 2026-04-29 |
|---|
| 2024-12-31 | Dr. Yuichi Iwaki | $1.41M | $1.61M | $424.60K | $474.78K | $102.44 | | $11.05M | | 2026-04-29 |
|---|
| 2023-12-31 | Dr. Yuichi Iwaki | $1.39M | $1.15M | $846.68K | $701.14K | $73.17 | | $8.57M | | 2026-04-29 |
|---|